États-Unis · Presse financière · Investor's Business Daily

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Publié par Investor's Business Daily · États-Unis il y a 2 h

Shares of Nurix Therapeutics crashed Wednesday after Sanofi unexpectedly scrapped an experimental eczema drug that two were codeveloping. The post Nurix, Sanofi Diverge — And One…

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

À lire aussi

U.S. Crude Oil Stockpiles Post Fifth Straight Weekly Drop

Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Partager

À lire aussi

U.S. Crude Oil Stockpiles Post Fifth Straight Weekly Drop

Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk